To date, there is no proven effective pharmacological treatment to initiate regeneration of joint tissues, and thus to change the course of the disease. Nevertheless, promising therapeutic…

Read more: Target the Knee as a Whole: Multimodal Approach to Injections in Osteoarthritis

Recently classified as a pandemic by the World Health Organization (WHO), the coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).…

Read more: The rationale for use of anti-rheumatic drugs for the management of COVID-19 patients

Rheumatoid arthritis (RA) is an autoimmune disease with genetic and environmental origins. It is a systemic disease that affects the joints and may also involve visceral organs such as the…

Read more: Does Air Pollution Have Anything to Do with Rheumatoid Arthritis?

Scleroderma is a rare autoimmune disease characterized by fibrosis of the trunk and extremities, often associated with early visceral involvement. Despite progress in its management,…

Read more: Autologous Hematopoietic Stem Cells May Be Beneficial for Severe Systemic Sclerosis

Children born to women with rheumatoid arthritis (RA) have a greater risk for certain chronic diseases, suggest new findings published in the journal Arthritis Care & Research. Prenatal…

Read more: Prenatal Exposure to RA May Raise the Risk of Epilepsy and Thyroid Disease

An ACR report tried to analyze a common question among clinicians without a clear answer even to date: May a history of cancer contribute to the overall risk of cancer occurrence related to…

Read more: The Risk for Second Cancer in RA Patients Treated with Biologics